Desiccation-Resistant Pseudomonas Strains for Agricultural Biocontrol

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biological control agents, such as Pseudomonads, face challenges in commercial production and application due to their sensitivity to desiccated storage conditions, limiting their effectiveness and longevity as antagonists against fungal diseases like Fusarium species in agricultural settings.

Innovation Solution

Development of novel strains of Pseudomonas fluorescens through engineered mutagenesis to enhance their tolerance to long-term dry storage, maintaining viability and bioefficacy when rehydrated, using selective pressure environments and stress conditions to select for desirable traits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Pseudomonads are used as biological control agents, then effectiveness against fungal diseases is improved, but tolerance to desiccated storage conditions deteriorates

Engineering Contradiction:
Improveeffectiveness as biological control agentVSAvoidsensitivity to desiccation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies engineered mutagenesis to alter the physiological parameters of Pseudomonas fluorescens strains, specifically enhancing their desiccation tolerance. This involves changing the bacterial cells' ability to withstand water loss through genetic modification, allowing them to survive in dry storage conditions while maintaining their biocontrol efficacy against Fusarium species.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the harmful effect of desiccation into a beneficial selection pressure. By subjecting Pseudomonas strains to controlled desiccation stress during the mutagenesis process, the method selects for mutants that have developed enhanced tolerance to drying conditions. These mutants then survive storage and application processes that would kill wild-type strains, turning a previously harmful condition into a tool for strain improvement.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Stability of the object's composition

If engineered mutagenesis is applied to enhance desiccation tolerance, then storage stability is improved, but strain complexity increases

Engineering Contradiction:
Improvestorage stabilityVSAvoidstrain complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent performs preliminary mutagenesis and selection of desiccation-tolerant mutants before the strains need to be stored. By pre-adapting the Pseudomonas fluorescens strains through engineered mutagenesis and selecting for desired traits under controlled conditions, the method ensures that the strains are already optimized for storage stability before commercial production and field application, avoiding the need for complex ongoing modifications.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If chemical-based control products are used, then disease control effectiveness is improved, but chemical resistance development worsens

Engineering Contradiction:
Improvedisease control effectivenessVSAvoidchemical resistance
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces chemical-based disease control mechanisms with a biological system. Instead of using chemical fungicides that exert selective pressure leading to resistance, the invention employs genetically modified Pseudomonas fluorescens strains that provide disease control through biological mechanisms such as competition, antibiosis, or induction of plant resistance. This substitution eliminates the evolution of chemical resistance while maintaining disease control effectiveness.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS10982185B2Desiccation resistant pseudomonad strains and treatment of agricultural maladies therewith
Publication Date: 2021.04.20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US10982185B2 patent drawing
  • US10982185B2 patent drawing
  • US10982185B2 patent drawing

AI summary

Novel strains of Pseudomonas fluorescens are disclosed. Several novel mutated strains of Pseudomonads are engineered by repetitive culturing of a parent strain under stressed conditions. Various enriched populations are screened and ranked based on relative performance indices including viable cell yield during growth, efficacy in suppression of dry rot disease, cell growth recovery after dry storage and resistance to switchgrass hydrolysate.